Clinical analysis of Astragalus treatment of angina pectoris.docVIP

 PAGE \* MERGEFORMAT 6 Clinical analysis of Astragalus treatment of angina pectoris Keywords:] injection, angina pectoris, blood lipids, nitric oxide, endothelin I received with astragalus good effect treatment of angina pectoris and coronary heart disease by observing their serum lipids, nitric oxide (NO), endothelin (ET) levels, to explore the treatment of crown mechanism for angina heart disease. 1 Materials and Methods 1.1 Clinical data Select January 2004 -2006 in our hospital in June of 90 patients with angina pectoris, all enrolled patients are in line with WTO / ISF 1979 enacted on the naming of ischemic heart disease and diagnostic criteria [1]. the selected patients were randomly divided into 2 groups of 45 patients. the treatment group 20 males and 25 females, aged 42 to 70 years (mean 52.74 + -9.31) years; the shortest duration of 2 weeks, up to 29 years (mean 15.23 + -4.31) years, 25 patients with stable angina, unstable angina in 20 cases. control group, 18 males and 27 females, aged from 45 to 71 years (mean 53.15 + -8.64) years, duration of 1 week minimum, up to 22 years (mean 16.78 + -5.17) years; stable angina in 28 cases, 17 cases of unstable angina patients .2 The data to compare the difference was not significant (Pgt; 0.05), comparable. 1.2 The case of the standard exclusion Angina Ⅳ, high-risk patients with unstable angina, cardiac neurosis, chest pain caused by cervical spondylosis, with severe hypertension (systolic blood pressuregt; = 180 mmHg, diastolic blood pressuregt; = 110 mmHg), severe heart and lung function failure and other serious disorders to restrict movement, heart valve disease and other heart disease caused angina, combined liver, kidney, hematopoietic system of primary and other serious diseases, mental illness and severe lipid disorder patients. 1.3 Treatment 2 groups were given conventional therapy, application of nitrates, calcium channel blockers, aspirin, β receptor blocking agent. The